Background and Purpose-Alberta Stroke Programme Early CT Score (ASPECTS) is a quantitative topographical score to evaluate early ischemic change in the middle cerebral arterial territory on CT as well as on diffusion-weighted imaging (DWI). The aim of the present study was to elucidate the relationship between CT-ASPECTS and DWI-ASPECTS for patients with hyperacute stroke and their associations with outcomes after recombinant tissue-type plasminogen activator therapy based on a multicenter registry. Methods-ASPECTS was assessed on both CT and DWI before intravenous 0.6 mg/kg alteplase in 360 patients with stroke (119 women, 71Ϯ11 years old). The outcomes were symptomatic intracerebral hemorrhage within 36 hours and independence at 3 months defined by a modified Rankin Scale score of 0 to 2. 
arly ischemic change (EIC) of the brain is predictive of the benefit from thrombolysis. 1-3 EIC on CT has been assessed by using the one third of cerebral hemisphere rule, and patients with extensive EIC are contraindicated for administration of intravenous recombinant tissue-type plasminogen activator (rtPA) within 3 to 4.5 hours of onset of acute ischemic stroke. 4 -6 The Alberta Stroke Programme Early CT Score (ASPECTS) was successfully developed to improve reliability for the detection of EIC on CT imaging. 7 However, EIC on CT is subtle and has poor intra-and interrater reliabilities. 8 MRI with diffusion-weighted imaging (DWI) is better than CT for detection of acute ischemic stroke. MRI could be used as the first-line modality for the emergent imaging of patients with acute stroke. 9, 10 ASPECTS has been recently applied to assess EIC on DWI. 11, 12 We reported that pretreatment ASPECTS on DWI was independently predictive of functional and vital outcomes at 3 months after rtPA therapy from single-center and multicenter registries. 13, 14 To our knowledge, EIC on CT has been compared with that on MRI before rtPA therapy using ASPECTS only in a few studies 15, 16 ; 1 small study, involving 22 patients with stroke, reported that ASPECTS on DWI seemed to be useful for predicting neurological deterioration after thrombolysis. 16 The aim of the present study was to elucidate the relationship between pretreatment ASPECTS assessed using CT and DWI before rtPA therapy and their associations with outcomes after stroke.
Subjects and Methods
The Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry was conducted using a multicenter hospital-based retrospective observational design. The details of this study have been described previously. 14, 17 In brief, a total of 600 consecutive patients with acute ischemic stroke receiving intravenous rtPA were registered from October 2005 (when intravenous alteplase therapy was approved in Japan) through July 2008 in 10 stroke centers in Japan. Patient eligibility for alteplase therapy was determined based on the Japanese guideline for intravenous rtPA therapy, which followed the inclusion and exclusion criteria used in the National Institute of Neurological Disorders and Stroke study and the Japan Alteplase Clinical Trial (J-ACT). 18, 19 According to the Japanese guidelines, 20 patients with CT-documented extensive EIC (size is not defined) were not eligible for the treatment. Because the guidelines do not refer to EIC on DWI, the eligibility of patients having large EIC on DWI depended on each physician's decision. Each local ethics committee approved the retrospective collection of clinical data from the database and submission of the data to our central office. Each patient received a single alteplase dose of 0.6 mg/kg (the recommended dose in Japanese guidelines and the approved labeling) intravenously with 10% given as a bolus within 3 hours of stroke onset followed by a continuous intravenous infusion of the remainder over 1 hour.
Baseline data, including sex, age, comorbidities (hypertension, diabetes, hyperlipidemia, and congestive heart failure), blood pressure on admission, time from onset to treatment, neurological deficits using the National Institutes of Health Stroke Scale score, and stroke subtype according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) categories, 21 were collected retrospectively from medical charts for all patients.
Assessment of ASPECTS on CT and DWI
Before rtPA infusion, MRI studies, including DWI and MR angiography, were begun principally after CT. Time of starting CT and MRI were collected from medical charts. Administration of rtPA was begun approximately 10 minutes after MRI. CT scans were performed in almost all centers according to a standard CT scan protocol (5-to 10-mm slice thickness without contrast enhancement, 120 kV, high tube current, low speed scan with Ն2 seconds/rotation, contrastfavored algorithm, inferior orbitomeatal baseline, filmed at appropriate window width of Ն80 Hounsfield units). MRI scans were performed on a 1.5-T scanner. MRI protocols were not entirely uniform in each center, but all included an axial DWI using a single-shot echoplanar imaging (bϭ1000 s/mm 2 , 5-to 6-mm-thick slices). The time required to perform CT was a few minutes and that of MRI was 10 to 15 minutes. ASPECTS assessed using DWI (DWI-ASPECTS) as well as original ASPECTS based on CT (CT-ASPECTS) was examined by each investigator in each center without using a central reading system. Thus, the reading results reflect real-life conditions. At least 2 experienced vascular neurologists or neurosurgeons in each stroke center evaluated the initial DWI and CT images to calculate quantitative EIC using ASPECTS later as a post hoc analysis. The interrater agreement of ASPECTS in our study group assessed using a sample of 76 CT and DWI images was ϭ0.634 for CT (PϽ0.001) and ϭ0.818 for DWI (PϽ0.001, Spearman rank test). Arterial occlusion was (principally) assessed on the initial MR angiography.
Outcomes
The outcomes were symptomatic intracerebral hemorrhage (sICH) within the initial 36 hours and independence at 3 months corresponding to a modified Rankin Scale score of 0 to 2. Intracerebral hemorrhage was defined as CT evidence of new parenchymal hemorrhage of Type I or Type II within the initial 36 hours 2 and was assessed by at least 2 experienced examiners. sICH was defined as a parenchymal intracerebral hemorrhage associated with neurological deterioration corresponding to an increase of Ն4 points from the baseline National Institutes of Health Stroke Scale score.
Statistical Analysis
Statistical analysis was performed using the JMP 8.0 statistical software (SAS Institute Inc, Cary, NC). The relationship between CT-ASPECTS and DWI-ASPECTS was assessed by Spearman rank test, the Bland and Altman plot, and an interrater correlation coefficient. Multiple linear regression was performed to identify the predictors for the discrepancy between CT-ASPECTS and DWI-ASPECTS based on the characteristics in Table 1 . CT-ASPECTS and DWI-ASPECTS in patients with middle cerebral artery occlusion were compared with those in patients without by the MannWhitney U test. Sensitivity and specificity of EIC on each region of Data are no. of patients (%), median (interquartile range) for discontinuous variables, and meanϮSD for continuous variables.
NIHSS indicates National Institutes of Health Stroke Scale score; ASPECTS, Alberta Stroke Programme Early CT Score; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging; CT, computed tomography; M1, middle cerebral artery trunk (horizonal segment); M2, middle cerebral artery branch (sylvian segment); M3, middle cerebral artery branch (cortical segment).
*Including patients who have insufficient-quality MR angiography.
CT-ASPECTS were assessed when setting DWI-ASPECTS as a standard. To evaluate the predictive ability of the CT-ASPECTS and DWI-ASPECTS for each outcome, receiver operating characteristic curves were constructed. The area under the receiver operating characteristic curve was used as a scalar measure to assess the performance of prognostic risk scores. The comparison of area under the receiver operating characteristic curves was conducted by nonparametric method. 22 Statistical significance was established at PϽ0.05.
Results
Of the total of 600 consecutive patients registered, the following 240 patients were deemed ineligible for the study: 109 patients who had a history of ischemic stroke; 20 who had premorbid modified Rankin Scale scores of 3 to 5; 58 who were not performed MRI due to contraindications, unsteadiness, or time limitation; 6 who had CT or DWI images of insufficient quality to evaluate EIC; 43 who had vertebrobasilar, posterior cerebral arterial, or anterior cerebral arterial territory strokes; and 3 who had missing data on 3-month modified Rankin Scale scores. Finally, 360 patients (241 men, 71Ϯ11 years old) were included in the study. Baseline clinical characteristics of the patients are presented in Table 1 . The median National Institutes of Health Stroke Scale score was 12 (interquartile range, 7 to 18). Time delay between CT and MRI was identified in 323 patients (89.7%); the median delay was 19 minutes (interquartile range, 12 to 29). The pretreatment DWI-ASPECTS was positively correlated with CT-ASPECTS (ϭ0.511, PϽ0.001, Spearman rank test; Figure 1A ). An interrater correlation coefficient between CT-ASPECTS and DWI-ASPECTS was 0.535. DWI-ASPECTS (median, 8; interquartile range, 6 to 9) was lower than CT-ASPECTS (9; 8 to 10; PϽ0.001). Figure 1B .001) were related to the discrepancy between CT-ASPECTS and DWI-ASPECTS. CT-ASPECTS was Ն8 in 286 patients (79.4%); of these, 21 patients (7.3%) had DWI-ASPECTS of Յ5. Of these 21 patients, 2 patients had sICH. CT-ASPECTS and DWI-ASPECTS (median, 9; interquartile range, 7 to 10 and 8; 6 to 9, respectively) in patients with middle cerebral artery occlusion were lower than those in patients without (median, 10; interquartile range, 9 to 10 and 9; 9 to 10, respectively; PϽ0.001 for both).
The sensitivity and specificity of EIC on each region of CT-ASPECTS when using DWI-ASPECTS as the gold standard are shown in Table 2 . The sensitivities of EICs in the caudate and internal capsule regions (13.0% and 18.0%, respectively) and the specificity of EIC in the lentiform nucleus (86.2%) were relatively low on CT.
Of 360 patients, 76 (21.1%) had any intracerebral hemorrhage, 12 (3.3%) had sICH, and 192 (53.3%) were independent (modified Rankin Scale 0 to 2). For prediction of sICH, the area under the receiver operating characteristic curve was 0.673 (95% CI, 0.503 to 0.807) for CT-ASPECTS and 0.764 (0.635 to 0.858) for DWI-ASPECTS (Pϭ0.275; Figure 2A ). For prediction of independence at 3 months, the area under the receiver operating characteristic curve was 0.621 (0.564 to 0.674) for CT-ASPECTS and 0.639 (0.580 to 0.694) for DWI-ASPECTS (Pϭ0.535; Figure 2B ).
Discussion
In this study, DWI-ASPECTS was positively related with CT-ASPECTS, scored lower than CT-ASPECTS, and was as useful as CT-ASPECTS for predicting functional outcomes in patients with hyperacute stroke who were scheduled to receive rtPA therapy. We elucidated the relationship between DWI-ASPECTS and CT-ASPECTS before rtPA therapy and their associations with outcomes after therapy. We followed much a previous study design by Barber et al 15 involving 100 patients within 6 hours of stroke onset. The strength of our study compared with the previous 1 was the larger sample size, shorter time interval between stroke onset and imaging examination, and shorter time interval between CT and DWI.
This study demonstrates that DWI-ASPECTS scored approximately 1 point lower than CT-ASPECTS in patients with stroke within 3 hours of onset. Previously, the reported difference of ASPECTS in both methods was 0.43 on average based on the previously mentioned study by Barber et al 15 and 1 when using the median based on another study involving 30 patients within 24 hours of stroke onset. 23 The time delay of MRI after CT, 102 minutes on average in the former study and 4.4 hours when using the median in the latter study, was proposed as a major reason for the discrepancy in AS-PECTS. 15, 23 Because the time delay was much smaller in the present study, the discrepancy in ASPECTS appears to be mainly due to the superior ability of DWI to delineate the extension of EIC as compared with CT.
The multivariate analysis indicated that when stroke subtype was cardioembolic and when the initial neurological deficits were severe, CT had the tendency to underestimate extension of EIC than DWI. The time delay of MRI after CT was not related to this discrepancy. Among regions of interest, the sensitivities of EICs in the caudate and internal capsule regions and the specificity of EIC in the lentiform nucleus were low on CT as compared with DWI. Thus, ASPECTS in the 2 modalities may not coincide, particularly in patients with severe cardioembolic stroke whose EICs lie extensively in the basal ganglia. CT seems to have a limitation for delineation of attenuation changes in the caudate and internal capsule regions as compared with that of sulcal effacement, focal cortical swelling, and loss of gray-white differentiation in the cortex because of the low sensitivity. The probable reason for the low specificity in the lentiform in the basal ganglia may be reversed discrepancy between CT and DWI. 24 Reversed discrepancy was identified mainly in the basal ganglia, and its pathophysiology may be pseudonormalization of apparent diffusion coefficient in EIC by early spontaneous reperfusion. 24 A critical limitation in our Table 2 was that the analysis was referenced to DWI, which incorporates both reversible and irreversible ischemia. The analysis should be fundamentally referenced to follow-up imaging, which represents final tissue status. However, our patients were treated with rtPA and natural courses of final tissue status could not be assessed.
Another unique finding in this study was comparison of CT-ASPECTS and DWI-ASPECTS as an outcome predictor. The area under the receiver operating characteristic curves for predicting outcomes with DWI-ASPECTS were somewhat, although not significantly, higher than those with CT-ASPECTS. DWI-ASPECTS appears to be at least equivalent to CT-ASPECTS in predicting sICH and stroke outcomes.
This study has several limitations. First, this was an observational study and patient eligibility for rtPA was determined according to each patient's situation, although the determination was principally based on the Japanese guidelines. 20 These guidelines might have contributed to selection bias. Second, all the patients were treated with 0.6 mg/kg alteplase. Thus, the clinical values of CT-ASPECTS and DWI-ASPECTS in patients treated with 0.9 mg/kg alteplase were not ascertained. Third, although we tried to perform CT and MRI as quickly as possible, onset to treatment time might have been somewhat longer than if only 1 of the examinations had been done. Finally, the present analysis was done only for patients without extensive EIC; this selection bias affects statistical results.
Our findings support the use of DWI-ASPECTS as well as CT-ASPECTS in predicting clinical outcomes after rtPA therapy. In addition, DWI-ASPECTS in our cohorts showed higher interrater reliability as compared with CT-ASPECTS as was reported in previous reports. 25, 26 DWI-ASPECTS is a promising scoring system to evaluate EIC for predicting reliable clinical outcomes in future clinical stroke trials.
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